Form 4: TELA Bio, Inc. Executive Megan Smeykal Reports Changes in Beneficial Ownership

Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reports a transaction involving the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Summary

• On March 31, 2025, Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., had 96 shares of common stock withheld by the issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
• The price per share was $1.22.
• Following the transaction, Smeykal directly owns 36,831 shares of TELA Bio, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't convey any particularly positive or negative sentiment regarding the company's performance or prospects.

Industry Context

This filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies. It provides transparency into insider transactions but doesn't necessarily indicate a significant shift in the company's financial health or strategic direction.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares withheld for tax purposes.

Key Dates

Keywords

Form 4, Beneficial Ownership, TELA Bio, Megan Smeykal, Insider Trading, SEC Filing, Stock Transaction, Common Stock, Tax Withholding